Mark Corrigan

CIK: 0001250661

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WVE

Wave Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

WVE
Wave Life Sciences, Inc.
Oct 5, 2026
Award(A)
Direct
10.7K shares-
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
9.6K shares at avg. $13.09$126K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
6.5K shares at avg. $14.06$92K
WVE
Wave Life Sciences Ltd.
Aug 11, 2025
Award(A)
Direct
12.7K shares-

		Type	Shares	Price		Ownership
Oct 5, 2026	WVE Wave Life Sciences, Inc.	Award(A)	10,700	-	$0	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	9,600	$13.09	$125,664	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	6,515	$14.06	$91,633	Direct
Aug 11, 2025	WVE Wave Life Sciences Ltd.	Award(A)	12,700	-	-	Direct

1-4 of 4 transactions

About CORRIGAN MARK

CORRIGAN MARK (SEC CIK 0001250661) files insider reports with the SEC as Director of Wave Life Sciences, Inc. (WVE).

Signal8 holds 3 ownership filings by CORRIGAN MARK, all Form 4s, filed between Aug 13, 2025 and Oct 7, 2026. Those filings report 4 transactions, from Aug 11, 2025 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CORRIGAN MARK's filings is in CAMBRIDGE, MA.

Recent filings by CORRIGAN MARK

Oct 5, 2026: Grant or award of WVE shares (Form 4, code A).
Dec 8, 2025: Open-market sales of WVE shares (2 lines, Form 4, code S).
Aug 11, 2025: Grant or award of WVE shares (Form 4, code A).

Other insiders filing for Wave Life Sciences, Inc. (WVE)

How to read Form 4 transaction codes